Galapagos (Belgium)

Publications in OpenAlex of which a co-author is affiliated to this organization

All publications | By field | By subfield

All publications [Next]
Title DOI
https://doi.org/10.1038/s41573-025-01308-z Quantitative systems toxicology: modelling to mechanistically understand and predict drug safety
https://doi.org/10.1523/jneurosci.3987-04.2004 Peroxisome Proliferator-Activated Receptor γ Induces a Clearance Mechanism for the Amyloid-β Peptide
https://doi.org/10.4161/cc.8.12.8810 At concentrations that inhibit mTOR, resveratrol suppresses cellular senescence
https://doi.org/10.1074/jbc.m306957200 Presenilins Mutated at Asp-257 or Asp-385 Restore Pen-2 Expression and Nicastrin Glycosylation but Remain Catalytically Inactive in the Absence of Wild Type Presenilin
https://doi.org/10.1111/j.1523-1739.2006.00423.x Predicting Pathogen Introduction: West Nile Virus Spread to Galápagos
https://doi.org/10.2174/1871520611313050008 Type II Kinase Inhibitors: An Opportunity in Cancer for Rational Design
https://doi.org/10.1111/j.1439-0310.1978.tb01843.x On the Biology of Tropidurus delanonis, Baur (Iguanidae)
https://doi.org/10.4161/cc.10.10.15789 The purpose of the HIF-1/PHD feedback loop: To limit mTOR-induced HIF-1α
https://doi.org/10.1002/art.24470 The α7 nicotinic acetylcholine receptor on fibroblast‐like synoviocytes and in synovial tissue from rheumatoid arthritis patients: A possible role for a key neurotransmitter in synovial inflammation
https://doi.org/10.1186/ar3119 A multiparameter approach to monitor disease activity in collagen-induced arthritis
https://doi.org/10.1016/b978-0-444-62652-3.00004-1 Advances in the Discovery of Selective JAK Inhibitors
https://doi.org/10.1653/0015-4040(2005)088[0159:eotlfa]2.0.co;2 ERADICATION OF THE LITTLE FIRE ANT, WASMANNIA AUROPUNCTATA (HYMENOPTERA: FORMICIDAE), FROM MARCHENA ISLAND, GALÁPAGOS: ON THE EDGE OF SUCCESS?
https://doi.org/10.1085/jgp.201912360 Identifying the molecular target sites for CFTR potentiators GLPG1837 and VX-770
https://doi.org/10.1016/s0166-0934(01)00257-9 Rapid determination of adenoviral vector titers by quantitative real-time PCR
https://doi.org/10.4161/cbt.5.1.2289 The role of relaxin in endometrial cancer
https://doi.org/10.1021/js9701061 Mechanical Properties of Compacts and Particles that Control Tableting Success
https://doi.org/10.1007/s10637-015-0320-9 A dose escalating phase I study of GLPG0187, a broad spectrum integrin receptor antagonist, in adult patients with progressive high-grade glioma and other advanced solid malignancies
https://doi.org/10.1085/jgp.201711886 A common mechanism for CFTR potentiators
https://doi.org/10.1002/art.38973 Effect of Certolizumab Pegol Over Ninety‐Six Weeks in Patients With Axial Spondyloarthritis: Results from a Phase III Randomized Trial
https://doi.org/10.1007/s13402-011-0058-0 BMP-7 inhibits TGF-β-induced invasion of breast cancer cells through inhibition of integrin β3 expression
https://doi.org/10.1017/s0376892903001188 The Galápagos sea cucumber fishery: management improves as stocks decline
https://doi.org/10.1021/acs.jmedchem.7b00647 Discovery, Structure–Activity Relationship, and Binding Mode of an Imidazo[1,2-a]pyridine Series of Autotaxin Inhibitors
https://doi.org/10.18268/bsgm2005v57n1a6 La falla Chacalapa en el sur de Oaxaca
https://doi.org/10.1021/jo400989q Strategy for the Synthesis of Pyridazine Heterocycles and Their Derivatives
https://doi.org/10.1021/acs.jmedchem.7b01288 Discovery ofN-(3-Carbamoyl-5,5,7,7-tetramethyl-5,7-dihydro-4H-thieno[2,3-c]pyran-2-yl)-lH-pyrazole-5-carboxamide (GLPG1837), a Novel Potentiator Which Can Open Class III Mutant Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Channels to a High Extent
https://doi.org/10.1021/acs.jcim.7b00642 Shedding Light on Important Waters for Drug Design: Simulations versus Grid-Based Methods
https://doi.org/10.2174/1872312810666151223103353 Clinical Confirmation that the Selective JAK1 Inhibitor Filgotinib (GLPG0634) has a Low Liability for Drug-drug Interactions
https://doi.org/10.4161/cc.8.22.10121 Cellular quiescence caused by the Mdm2 inhibitor Nutlin-3A
https://doi.org/10.1016/j.jcf.2019.04.014 CFTR activity is enhanced by the novel corrector GLPG2222, given with and without ivacaftor in two randomized trials
https://doi.org/10.3390/cancers11030359 RETRACTED: The Small Molecule Ephrin Receptor Inhibitor, GLPG1790, Reduces Renewal Capabilities of Cancer Stem Cells, Showing Anti-Tumour Efficacy on Preclinical Glioblastoma Models
https://doi.org/10.1007/s10592-005-8704-6 Population Genetic Structure and Conservation of the Galápagos Petrel (Pterodroma phaeopygia)
https://doi.org/10.1038/onc.2011.594 Identification of phosphorylase kinase as a novel therapeutic target through high-throughput screening for anti-angiogenesis compounds in zebrafish
https://doi.org/10.1038/s41598-017-18159-3 Three classes of ligands each bind to distinct sites on the orphan G protein-coupled receptor GPR84
https://doi.org/10.1111/jdv.16126 IL‐17C amplifies epithelial inflammation in human psoriasis and atopic eczema
https://doi.org/10.1136/vr.c6520 Sterilisation of hybrid Galapagos tortoises ( Geochelone nigra ) for island restoration. Part 1: endoscopic oophorectomy of females under ketamine‐medetomidine anaesthesia
https://doi.org/10.1021/ml400095m Identification of a Series of Compounds with Potent Antiviral Activity for the Treatment of Enterovirus Infections
https://doi.org/10.1890/13-0169.1 Oceanographic and climatic variation drive top‐down/bottom‐up coupling in the Galápagos intertidal meta‐ecosystem
https://doi.org/10.1002/cbic.200600189 REPLACE: A Strategy for Iterative Design of Cyclin‐Binding Groove Inhibitors
https://doi.org/10.1097/ncn.0b013e3181f9db79 The Use of Bedside Electronic Medical Record to Improve Quality of Care in Nursing Facilities
https://doi.org/10.1097/ncn.0b013e3181f69838 Improving Nurse Care Coordination With Technology
https://doi.org/10.1002/jcph.1424 Safety, Pharmacokinetics, and Pharmacodynamics of the Autotaxin Inhibitor GLPG1690 in Healthy Subjects: Phase 1 Randomized Trials
https://doi.org/10.3389/fphar.2018.01221 Identification and Characterization of Novel CFTR Potentiators
https://doi.org/10.3899/jrheum.201183 Safety and Efficacy of Filgotinib: Up to 4-year Results From an Open-label Extension Study of Phase II Rheumatoid Arthritis Programs
https://doi.org/10.4103/0972-4923.101835 Understanding Science in Conservation: A Q Method Approach on the Galápagos Islands
https://doi.org/10.3389/fphar.2019.00514 Identification of GLPG/ABBV-2737, a Novel Class of Corrector, Which Exerts Functional Synergy With Other CFTR Modulators
https://doi.org/10.3390/ijerph16050682 Socio-Ecological Factors Associated with Dengue Risk and Aedes aegypti Presence in the Galápagos Islands, Ecuador
https://doi.org/10.1016/j.jcf.2018.05.011 Physiological and pharmacological characterization of the N1303K mutant CFTR
https://doi.org/10.1016/j.chemosphere.2021.129821 Heavy metal contents, mobility and origin in agricultural topsoils of the Galápagos Islands
https://doi.org/10.1111/j.1469-1795.2012.00567.x Applying the tools of ecological immunology to conservation: a test case in the Galapagos sea lion
https://doi.org/10.1098/rspa.2008.0278 Theory of quantum arrival and spatial wave function collapse on the appearance of particle
https://doi.org/10.1186/s13045-017-0530-z Pharmacological targeting of the ephrin receptor kinase signalling by GLPG1790 in vitro and in vivo reverts oncophenotype, induces myogenic differentiation and radiosensitizes embryonal rhabdomyosarcoma cells
https://doi.org/10.1039/c8nj01544a Metal–azole fungistatic drug complexes as anti-Sporothrixspp. agents
https://doi.org/10.1111/jcpe.12271 Non‐surgical and supportive periodontal therapy: predictors of compliance
https://doi.org/10.1186/1471-2148-9-297 Progressive colonization and restricted gene flow shape island-dependent population structure in Galápagos marine iguanas (Amblyrhynchus cristatus)
https://doi.org/10.1016/j.yrtph.2017.08.008 A consortium-driven framework to guide the implementation of ICH M7 Option 4 control strategies
https://doi.org/10.1071/sr18331 Agriculture changes soil properties on the Galápagos Islands – two case studies
https://doi.org/10.1038/s41388-020-01396-8 USP13 controls the stability of Aurora B impacting progression through the cell cycle
https://doi.org/10.1016/bs.pmch.2018.01.001 Recent Progress in the Discovery and Development of Small-Molecule Modulators of CFTR
https://doi.org/10.1007/s10822-021-00405-6 Multitask machine learning models for predicting lipophilicity (logP) in the SAMPL7 challenge
https://doi.org/10.1016/bs.pmch.2020.02.001 Discovery and development of ASK1 inhibitors
https://doi.org/10.1002/art.42477 A 24‐Week, Phase IIa, Randomized, Double‐Blind, Placebo‐Controlled Study of Ziritaxestat in Early Diffuse Cutaneous Systemic Sclerosis
https://doi.org/10.1124/jpet.119.261800 Biological Characterization of F508delCFTR Protein Processing by the CFTR Corrector ABBV-2222/GLPG2222
https://doi.org/10.1039/d0mo00189a A novel multi-omics-based highly accurate prediction of symptoms, comorbid conditions, and possible long-term complications of COVID-19
https://doi.org/10.1183/13993003.01581-2021 Evaluation of a novel CFTR potentiator in COPD ferrets with acquired CFTR dysfunction
https://doi.org/10.14309/ajg.0000000000001979 Rapid and Sustained Symptom Relief in Patients With Ulcerative Colitis Treated With Filgotinib: Data From the Phase 2b/3 SELECTION Trial
https://doi.org/10.1016/j.jcf.2019.05.006 GLPG1837, a CFTR potentiator, in p.Gly551Asp (G551D)-CF patients: An open-label, single-arm, phase 2a study (SAPHIRA1)
https://doi.org/10.1136/annrheumdis-2019-eular.8676 LB0001 EFFICACY AND SAFETY OF FILGOTINIB FOR PATIENTS WITH RHEUMATOID ARTHRITIS WITH INADEQUATE RESPONSE TO METHOTREXATE: FINCH1 PRIMARY OUTCOME RESULTS
https://doi.org/10.3389/fmed.2021.711194 Patient Reported Experiences and Delays During the Diagnostic Pathway for Pulmonary Fibrosis: A Multinational European Survey
https://doi.org/10.1186/s12931-022-01976-0 Epidemiology, healthcare utilization, and related costs among patients with IPF: results from a German claims database analysis
https://doi.org/10.1093/rheumatology/kez408 Effect of filgotinib on health-related quality of life in active psoriatic arthritis: a randomized phase 2 trial (EQUATOR)
https://doi.org/10.1111/cobi.13319 Genetically informed captive breeding of hybrids of an extinct species of Galapagos tortoise
https://doi.org/10.1016/j.joca.2021.08.012 Pharmacological characterization of GLPG1972/S201086, a potent and selective small-molecule inhibitor of ADAMTS5
https://doi.org/10.1021/ol501529z Synthesis of Fused 3-Aminoazepinones via Trapping of a New Class of Cyclic Seven-Membered Allenamides with Furan
https://doi.org/10.1093/ecco-jcc/jjad022 Mercaptopurine for the Treatment of Ulcerative Colitis: A Randomized Placebo-Controlled Trial
https://doi.org/10.1136/annrheumdis-2012-202221 Oral administration of GLPG0259, an inhibitor of MAPKAPK5, a new target for the treatment of rheumatoid arthritis: a phase II, randomised, double-blind, placebo-controlled, multicentre trial
https://doi.org/10.1093/rheumatology/keab758 Filgotinib decreases both vertebral body and posterolateral spine inflammation in ankylosing spondylitis: results from the TORTUGA trial
https://doi.org/10.1002/cpdd.1042 Safety, Pharmacokinetics, and Pharmacodynamics of the ADAMTS‐5 Inhibitor GLPG1972/S201086 in Healthy Volunteers and Participants With Osteoarthritis of the Knee or Hip
https://doi.org/10.1093/ecco-jcc/jjac058 The Impact of Vedolizumab and Ustekinumab on Articular Extra-Intestinal Manifestations in Inflammatory Bowel Disease Patients: A Real-Life Multicentre Cohort Study
https://doi.org/10.1002/ejoc.201402983 Synthesis of Furans through Silver‐Catalyzed Propargyl–Claisen Rearrangement Followed by Cyclocondensation
https://doi.org/10.1021/acs.jmedchem.0c01796 Discovery of GLPG2451, a Novel Once Daily Potentiator for the Treatment of Cystic Fibrosis
https://doi.org/10.1016/j.marenvres.2022.105696 The impact of climate change on the distribution of Sphyrna lewini in the tropical eastern Pacific
https://doi.org/10.1136/rmdopen-2022-002658 Treat-to-target in rheumatoid arthritis: a real-world study of the application and impact of treat-to-target within the wider context of patient management, patient centricity and advanced therapy use in Europe
https://doi.org/10.37135/ee.004.07.09 Preeclampsia - eclampsia diagnóstico y tratamiento
https://doi.org/10.3390/ijms22105361 A 3D Renal Proximal Tubule on Chip Model Phenocopies Lowe Syndrome and Dent II Disease Tubulopathy
https://doi.org/10.1038/s41467-022-31280-w The genomic basis of the plant island syndrome in Darwin’s giant daisies
https://doi.org/10.1007/s10393-019-01456-w Water Security in the Galápagos: Socioecological Determinants and Health Implications
https://doi.org/10.1165/rcmb.2019-0291oc Novel Correctors and Potentiators Enhance Translational Readthrough in CFTR Nonsense Mutations
https://doi.org/10.1002/ece3.7807 Cooperation and opportunism in Galapagos sea lion hunting for shoaling fish
https://doi.org/10.1093/ecco-jcc/jjab232.017 OP18 Efficacy and safety of filgotinib for the treatment of perianal fistulizing Crohn’s Disease: Results from the phase 2 DIVERGENCE 2 study
https://doi.org/10.1093/ibd/izab330 Inadequate Response, Treatment Patterns, Health Care Utilization, and Associated Costs in Patients With Ulcerative Colitis: Retrospective Cohort Study Based on German Claims Data
https://doi.org/10.1111/apt.17674 Integrated safety analysis of filgotinib for ulcerative colitis: Results from SELECTION and SELECTIONLTE
https://doi.org/10.4155/ppa.14.23 Toward Selective TYK2 Inhibitors As Therapeutic Agents for the Treatment of Inflammatory Diseases
https://doi.org/10.1111/j.1526-100x.2012.00891.x Population Response of Giant Galápagos Tortoises to Feral Goat Removal
https://doi.org/10.1136/annrheumdis-2016-eular.3862 THU0173 Filgotinib (GLPG0634), An Oral Jak1 Selective Inhibitor Is Effective as Monotherapy in Patients with Active Rheumatoid Arthritis: Results from A 24-Week Phase 2B Dose Ranging Study
https://doi.org/10.1093/mr/roab030 Efficacy and safety of filgotinib in combination with methotrexate in Japanese patients with active rheumatoid arthritis who have an inadequate response to methotrexate: Subpopulation analyses of 24-week data of a global phase 3 study (FINCH 1)
https://doi.org/10.55563/clinexprheumatol/vuc5py Performance of the 2017 EULAR/ACR Classification Criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups: a scoping review
https://doi.org/10.1136/annrheumdis-2019-eular.8678 LB0003 EFFICACY AND SAFETY OF FILGOTINIB FOR PATIENTS WITH RHEUMATOID ARTHRITIS NAïVE TO METHOTREXATE THERAPY: FINCH3 PRIMARY OUTCOME RESULTS
https://doi.org/10.5217/ir.2021.00143 Efficacy and safety of filgotinib as induction and maintenance therapy for Japanese patients with moderately to severely active ulcerative colitis: a post-hoc analysis of the phase 2b/3 SELECTION trial
https://doi.org/10.1136/annrheumdis-2016-eular.1954 OP0224 Filgotinib (GLPG0634), An Oral Jak1 Selective Inhibitor Is Effective in Combination with Methotrexate in Patients with Active Rheumatoid Arthritis: Results from A 24-Week Phase 2B Dose Ranging Study
https://doi.org/10.1111/rec.13476 Introduction of giant tortoises as a replacement “ecosystem engineer” to facilitate restoration of Santa Fe Island, Galapagos